IZTC

Invizyne Technologies Inc. (IZTC)

Delisted
NASDAQ (CM) NASDAQ (CM)
Want to track IZTC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

IZTC is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on NASDAQ (CM) (USD).

Invizyne Technologies Inc. Profile

Biotechnology Industry
Healthcare Sector
Mr. Michael Heltzen CEO
NASDAQ (CM) Exchange
US4618741098 ISIN
US Country
29 Employees
- Last Dividend
- Last Split
- IPO Date
Invizyne Technologies, Inc. operates as a synthetic biochemical company in the United States. The company develops SimplePath, a platform that produces chemicals, including pharmaceuticals, fuels, materials, food additives, and novel compounds. Its platform also comprises one or more module which consist of one or more enzymes that work together to perform a defined biocatalytic conversion. The company was founded in 2014 and is headquartered in Monrovia, California.

Contact Information

Address: 750 Royal Oaks Drive
Phone: 626 415 1488